盆腔静脉功能不全患者血管内治疗后肌肉减少症对预后的影响。

IF 2.9 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

CardioVascular and Interventional Radiology Pub Date : 2025-07-01 Epub Date: 2025-05-23 DOI:10.1007/s00270-025-04051-5

Sinan Sozutok, Ferhat Can Piskin, Omer Kaya, Hasan Bilen Onan, Huseyin Tugsan Balli, Erol Huseyin Aksungur

{"title":"盆腔静脉功能不全患者血管内治疗后肌肉减少症对预后的影响。","authors":"Sinan Sozutok, Ferhat Can Piskin, Omer Kaya, Hasan Bilen Onan, Huseyin Tugsan Balli, Erol Huseyin Aksungur","doi":"10.1007/s00270-025-04051-5","DOIUrl":null,"url":null,"abstract":"Purpose: To investigate the influence of sarcopenia on the outcomes of endovascular treatment in patients with pelvic venous insufficiency (PVI).Material and methods: A retrospective analysis was conducted on 62 female patients who underwent endovascular treatment for PVI between January 2012 and July 2020. The patients were evaluated using the Visual Analog Scale (VAS) for chronic pelvic pain, both before treatment and three months post-treatment. A successful treatment outcome was defined as a reduction in pelvic pain by 50% or more. Sarcopenia was diagnosed based on the skeletal muscle mass index (SMI) of the patients.Results: Sarcopenia was present in 20 (32.3%) patients. There was no significant difference in preprocedural VAS scores between sarcopenic and non-sarcopenic patients (36.2 ± 16.9 vs. 34.9 ± 16.1, p = 0.781). However, non-sarcopenic patients achieved a significantly greater reduction in VAS scores post-treatment (67.6 ± 22.4% vs. 53.1 ± 24.4%, p = 0.025). A moderate negative correlation was observed between sarcopenia and successful treatment outcomes (r = -0.365, p = 0.004).Conclusion: Sarcopenia negatively impacts the effectiveness of endovascular treatment in patients with PVI.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"992-999"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267308/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Sarcopenia on Outcomes Following Endovascular Treatment of Patients with Pelvic Venous Insufficiency.\",\"authors\":\"Sinan Sozutok, Ferhat Can Piskin, Omer Kaya, Hasan Bilen Onan, Huseyin Tugsan Balli, Erol Huseyin Aksungur\",\"doi\":\"10.1007/s00270-025-04051-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: To investigate the influence of sarcopenia on the outcomes of endovascular treatment in patients with pelvic venous insufficiency (PVI).Material and methods: A retrospective analysis was conducted on 62 female patients who underwent endovascular treatment for PVI between January 2012 and July 2020. The patients were evaluated using the Visual Analog Scale (VAS) for chronic pelvic pain, both before treatment and three months post-treatment. A successful treatment outcome was defined as a reduction in pelvic pain by 50% or more. Sarcopenia was diagnosed based on the skeletal muscle mass index (SMI) of the patients.Results: Sarcopenia was present in 20 (32.3%) patients. There was no significant difference in preprocedural VAS scores between sarcopenic and non-sarcopenic patients (36.2 ± 16.9 vs. 34.9 ± 16.1, p = 0.781). However, non-sarcopenic patients achieved a significantly greater reduction in VAS scores post-treatment (67.6 ± 22.4% vs. 53.1 ± 24.4%, p = 0.025). A moderate negative correlation was observed between sarcopenia and successful treatment outcomes (r = -0.365, p = 0.004).Conclusion: Sarcopenia negatively impacts the effectiveness of endovascular treatment in patients with PVI.\",\"PeriodicalId\":9591,\"journal\":{\"name\":\"CardioVascular and Interventional Radiology\",\"volume\":\" \",\"pages\":\"992-999\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267308/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CardioVascular and Interventional Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00270-025-04051-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CardioVascular and Interventional Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00270-025-04051-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

目的：探讨肌肉减少症对盆腔静脉功能不全（PVI）患者血管内治疗效果的影响。材料与方法：回顾性分析2012年1月至2020年7月接受血管内治疗的62例女性PVI患者。在治疗前和治疗后3个月，采用视觉模拟量表（VAS）对患者进行慢性盆腔疼痛的评估。一个成功的治疗结果被定义为盆腔疼痛减少50%或更多。根据骨骼肌质量指数（SMI）诊断骨骼肌减少症。结果：20例（32.3%）患者出现肌肉减少症。肌少症与非肌少症患者术前VAS评分差异无统计学意义（36.2±16.9∶34.9±16.1,p = 0.781）。然而，非肌少症患者治疗后VAS评分下降明显更大（67.6±22.4%比53.1±24.4%,p = 0.025）。肌肉减少症与成功治疗结果之间存在中度负相关（r = -0.365, p = 0.004）。结论：肌少症对PVI患者血管内治疗的效果有负面影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Impact of Sarcopenia on Outcomes Following Endovascular Treatment of Patients with Pelvic Venous Insufficiency.

Purpose: To investigate the influence of sarcopenia on the outcomes of endovascular treatment in patients with pelvic venous insufficiency (PVI).

Material and methods: A retrospective analysis was conducted on 62 female patients who underwent endovascular treatment for PVI between January 2012 and July 2020. The patients were evaluated using the Visual Analog Scale (VAS) for chronic pelvic pain, both before treatment and three months post-treatment. A successful treatment outcome was defined as a reduction in pelvic pain by 50% or more. Sarcopenia was diagnosed based on the skeletal muscle mass index (SMI) of the patients.

Results: Sarcopenia was present in 20 (32.3%) patients. There was no significant difference in preprocedural VAS scores between sarcopenic and non-sarcopenic patients (36.2 ± 16.9 vs. 34.9 ± 16.1, p = 0.781). However, non-sarcopenic patients achieved a significantly greater reduction in VAS scores post-treatment (67.6 ± 22.4% vs. 53.1 ± 24.4%, p = 0.025). A moderate negative correlation was observed between sarcopenia and successful treatment outcomes (r = -0.365, p = 0.004).

Conclusion: Sarcopenia negatively impacts the effectiveness of endovascular treatment in patients with PVI.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

CardioVascular and Interventional Radiology 医学-核医学

CiteScore

5.50

自引率

13.80%

发文量

306

审稿时长

3-8 weeks

期刊介绍： CardioVascular and Interventional Radiology (CVIR) is the official journal of the Cardiovascular and Interventional Radiological Society of Europe, and is also the official organ of a number of additional distinguished national and international interventional radiological societies. CVIR publishes double blinded peer-reviewed original research work including clinical and laboratory investigations, technical notes, case reports, works in progress, and letters to the editor, as well as review articles, pictorial essays, editorials, and special invited submissions in the field of vascular and interventional radiology. Beside the communication of the latest research results in this field, it is also the aim of CVIR to support continuous medical education. Articles that are accepted for publication are done so with the understanding that they, or their substantive contents, have not been and will not be submitted to any other publication.